Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Controlled Release

• Publication date

  2007-08-28

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/J.JCONREL.2007.05.026PMID 17628165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.

  2007cited by this paper
• Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery.

  2007cited by this paper
• Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.

  2006cited by this paper
• Radioisotopic Tracing Method of Hirulog-like Peptide

  2006cited by this paper
• Nasal drug administration: potential for targeted central nervous system delivery.

  2005cited by this paper
• Intranasal drug delivery for brain targeting.

  2005cited by this paper
• The influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo.

  2005cited by this paper
• The use of human nasal in vitro cell systems during drug discovery and development.

  2005cited by this paper
• Glycoconjugate Expression in Normal Human Inferior Turbinate Mucosa: A Lectin Histochemical Study

  2005cited by this paper
• Preparation, characterization and application of pyrene-loaded methoxy poly(ethylene glycol)–poly(lactic acid) copolymer nanoparticles

  2004cited by this paper
• Lectin-mediated drug targeting: history and applications.

  2004cited by this paper
• Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

  2003cited by this paper
• Passage of vasoactive intestinal peptide across the blood-brain barrier.

  2003cited by this paper
• Detangling Alzheimer's disease. New insights into the biological bases of the most common cause of dementia are pointing to better diagnostics and possible therapeutics.

  2003cited by this paper
• Poly-L-Arginine Predominantly Increases the Paracellular Permeability of Hydrophilic Macromolecules Across Rabbit Nasal Epithelium in Vitro

  2003cited by this paper
• Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport

  2002cited by this paper
• Design of biodegradable particles for protein delivery.

  2002cited by this paper
• Delivery of Neurotrophic Factors to the Central Nervous System

  2001cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• In Vivo Gene Transfer to the Mouse Nasal Cavity Mucosa Using a Stable Cationic Lipid Emulsion

  2000cited by this paper
• [Olfactory epithelium of the rat. Lectin-mediated histochemical studies]

  1998cited by this paper
• Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration

  1998cited by this paper
• VIP Neurotrophism in the Central Nervous System: Multiple Effectors and Identification of a Femtomolar‐Acting Neuroprotective Peptide

  1998cited by this paper
• Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway

  1998cited by this paper
• [Olfactory epithelium of the rat. Lectin-mediated histochemical studies].

  1998cited by this paper
• Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

  1996cited by this paper
• VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment

  1995cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• Lectin histochemical localization of galactose, N-acetylgalactosamine, and N-acetylglucosamine in glycoconjugates of the rat vomeronasal organ, with comparison to the olfactory and septal mucosae

  1994cited by this paper
• In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-camera.

  1994cited by this paper
• Estimation of variance for AUC in animal studies.

  1993cited by this paper
• Neurotrophic Strategies for Treating Alzheimer's Disease: Lessons from Basic Neurobiology and Animal Models a

  1993cited by this paper
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

  1993cited by this paper
• (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.

  1991cited by this paper
• Immunopathology of olfactory mucosa following injury to the olfactory bulb

  1990cited by this paper
• (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.

  1989cited by this paper
• Behavioural and histological effects of low concentrations of intraventricular AF64A.

  1989cited by this paper
• Behavioral and neurochemical effects of intraventricular AF64A administration in rats.

  1984cited by this paper
• Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.

  1981cited by this paper
• Choline analogs as potential tools in developing selective animal models of central cholinergic hypofunction.

  1980cited by this paper
• Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide.

  1980cited by this paper
• Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.

  1979cited by this paper
• Polypeptide with Broad Biological Activity: Isolation from Small Intestine

  1970cited by this paper

• Overcoming translational barriers in nose-to-brain drug delivery for clinical applications.

  2026cites this paper
• Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease.

  2025cites this paper
• Intranasal Therapeutics for Neurodegenerative Disorders: Overcoming the Blood-Brain Barrier with Smart Formulations and Devices.

  2025cites this paper
• Challenges and strategies for nose-to-brain delivery in treating neurological disorders

  2025cites this paper
• Intranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview

  2025cites this paper
• Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• Emerging pharmacological targets for alcohol use disorder.

  2024cites this paper
• From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment

  2024cites this paper
• Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides.

  2024cites this paper
• The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease

  2023cites this paper
• Nanoparticles for the potential treatment of Alzheimer’s disease: A physiopathological approach

  2023cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper
• Recent Advances in Delivery of Peptide and Protein Therapeutics to the Brain

  2023cites this paper
• A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin.

  2023cites this paper
• Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems

  2023cites this paper
• Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

  2023cites this paper
• Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review

  2023influential citation
• Transnasal-brain delivery of nanomedicines for neurodegenerative diseases

  2023cites this paper
• Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting

  2023influential citation
• Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming

  2022cites this paper
• Current Approaches to Facilitate Improved Drug Delivery to the Central Nervous System.

  2022cites this paper
• Exploring Glycan Binding Specificity of Odorranalectin by Alanine Scanning Library.

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery

  2022cites this paper
• Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins

  2022cites this paper
• Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors

  2022cites this paper
• Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's

  2022cites this paper
• Advances in designing of polymeric micelles for biomedical application in brain related diseases.

  2022cites this paper
• Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

  2021cites this paper
• Characterization of Bioadhesion, Mucin‐interactions and Mucosal Permeability of Pharmaceutical Nano‐ and Microsystems

  2021cites this paper
• Nanomedicines for Brain Drug Delivery

  2021cites this paper
• Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA

  2021influential citation
• Nanoparticles for direct nose-to-brain drug delivery: Implications of targeting approaches

  2021cites this paper
• Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.

  2021cites this paper
• Wheat Germ Agglutinin—From Toxicity to Biomedical Applications

  2021cites this paper
• Potential applications of nanomedicine for treating Parkinson's disease

  2021cites this paper
• Particulate carriers for nose-to-brain delivery

  2021cites this paper
• Nose-to-brain delivery of biologics and stem cells

  2021cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Potential of naso-brain drug delivery in glioblastoma therapy

  2021cites this paper
• NOSE-TO-BRAIN DRUG DELIVERY: AN UPDATE TO THE ALTERNATIVE PATH TO SUCCESSFUL TARGETED ANTI-MIGRAINE DRUGS

  2021influential citation
• Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.

  2021cites this paper
• Intranasal route: The green corridor for Alzheimer's disease therapeutics

  2021cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer

  2021cites this paper
• Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

  2021cites this paper
• Surface modification of nanocarriers as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Functionalized carbon nano onion as a novel drug delivery system for brain targeting

  2021cites this paper
• Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer’s Disease: A State-of-the-Art (2017–2020)

  2020cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Novel perspectives for delivery of bioactives through blood–brain barrier and treatment of brain diseases

  2020cites this paper
• A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems

  2020cites this paper
• Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles

  2020cites this paper
• Nose-to-Brain Drug Delivery Enabled by Nanocarriers

  2020cites this paper
• Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems

  2020cites this paper
• Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

  2020cites this paper
• Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

  2020cites this paper
• Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer's Disease: A Recent Update.

  2020cites this paper
• Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.

  2020cites this paper
• Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease.

  2020cites this paper
• Nasal Bioadhesive Drug Delivery Systems and Their Applications

  2020cites this paper
• Advances in Nanocarrier-Based Delivery of Therapeutic Peptides

  2020cites this paper
• Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.

  2020cites this paper
• Nanoneuromedicine for management of neurodegenerative disorder

  2019cites this paper
• Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview

  2019cites this paper
• Photo-triggered Drug Delivery Systems for Neuron-related Applications.

  2019cites this paper
• Poly(lactic acid) and poly(lactic-co-glycolic) acid nanoparticles: versatility in biomedical applications

  2019cites this paper
• Design and Fabrication of Brain-Targeted Drug Delivery

  2019cites this paper
• Nanoparticle systems for nose-to-brain delivery

  2019cites this paper
• Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease.

  2019cites this paper
• Nanotherapeutic strategies for the treatment of neurodegenerative diseases

  2019cites this paper
• Strategies to facilitate or block nose-to-brain drug delivery.

  2019cites this paper
• Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.

  2019cites this paper
• Effective encapsulation of apomorphine into biodegradable polymeric nanoparticles through a reversible chemical bond for delivery across the blood-brain barrier.

  2019cites this paper
• Nanopharmaceuticals: A Boon to the Brain-Targeted Drug Delivery

  2019cites this paper
• Evaluation of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer nanomicelle for trigeminal ganglion neurons delivering with intranasal administration

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018influential citation
• 1 Surface-modified nanocarriers for nose-to-brain 2 delivery : from bioadhesion to targeting 3

  2018cites this paper
• A Feasibility Research on Restoration of Demyelination in Trigeminal Nerve with Transnasal Administration of BDNF/ NGF Loading on PEG-PLA Nanoparticles

  2018cites this paper
• Reply to the Reviewer’s Comments

  2018cites this paper
• Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• Peer-reviewed version of the manuscript published in final form at Chemical Society Reviews (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications

  2018cites this paper
• Ligand conjugation: An emerging platform for enhanced brain drug delivery.

  2018cites this paper
• Envisioning the future of polymer therapeutics for brain disorders.

  2018cites this paper
• Nanotechnology in brain targeting

  2018cites this paper
• Nanomaterials in Neural‐Stem‐Cell‐Mediated Regenerative Medicine: Imaging and Treatment of Neurological Diseases

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

  2018cites this paper
• Intranasal delivery of N‐terminal modified leptin‐pluronic conjugate for treatment of obesity

  2017cites this paper
• The effects of vasoactive intestinal peptide in neurodegenerative disorders

  2017cites this paper
• Using catanionic solid lipid nanoparticles with wheat germ agglutinin and lactoferrin for targeted delivery of etoposide to glioblastoma multiforme

  2017cites this paper
• INTRANASAL ROUTE FOR CNS DELIVERY: OVERVIEW AND RECENT ADVANCEMENTS

  2017cites this paper
• Intranasal VIP safely restores volume to multiple grey matter nuclei in patients with CIRS

  2017cites this paper
• Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse.

  2017cites this paper
• The Medical Applications of Nanomaterials in the Central Nervous System

  2017cites this paper
• Chapter 12 – Alzheimer

  2017cites this paper
• Lectin-Carbohydrate Interactions: Implications for the Development of New Anticancer Agents.

  2017cites this paper
• Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment

  2017cites this paper